145 related articles for article (PubMed ID: 4808306)
1. Medical complications associated with the use of methadone: methadone related mortality.
Greene MH; DuPont RL
Proc Natl Conf Methadone Treat; 1973; 2():811-23. PubMed ID: 4808306
[No Abstract] [Full Text] [Related]
2. Opiate overdose deaths in the District of Columbia. II. Methadone-related fatalities.
Greene MH; Luke JL; DuPont RL
J Forensic Sci; 1974 Jul; 19(3):575-84. PubMed ID: 4604856
[No Abstract] [Full Text] [Related]
3. Methadone diversion.
Bourne PG
Proc Natl Conf Methadone Treat; 1973; 2():839-41. PubMed ID: 4808308
[No Abstract] [Full Text] [Related]
4. Methadone fatalities in heroin addicts.
Roizin L; Helpern M; Baden M; Kaufman M; Hashimoto S; Liu JC; Eisenberg B
Psychiatr Q; 1972; 46(3):393-410. PubMed ID: 4661201
[No Abstract] [Full Text] [Related]
5. Methadone- and heroin-related deaths in Florida.
Graham NA; Merlo LJ; Goldberger BA; Gold MS
Am J Drug Alcohol Abuse; 2008; 34(3):347-53. PubMed ID: 18428077
[TBL] [Abstract][Full Text] [Related]
6. Acute opiate overdose: a preliminary report on mechanisms of death.
Greene MH; Luke JL; DuPont RL
Proc Natl Conf Methadone Treat; 1973; 1():330-5. PubMed ID: 4808166
[No Abstract] [Full Text] [Related]
7. The decline of heroin addiction in the District of Columbia.
DuPont RL; Green MH
Proc Natl Conf Methadone Treat; 1973; 2():1474-83. PubMed ID: 4808302
[No Abstract] [Full Text] [Related]
8. Heroin addiction trends.
Greene MH; Dupont RL
Am J Psychiatry; 1974 May; 131(5):545-50. PubMed ID: 4819047
[No Abstract] [Full Text] [Related]
9. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
Morgan O; Griffiths C; Hickman M
Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
[TBL] [Abstract][Full Text] [Related]
10. Patterns of heroin addiction in the District of Columbia.
DuPont RL; Greene MH
Proc Natl Conf Methadone Treat; 1973; 1():786-93. PubMed ID: 4808234
[No Abstract] [Full Text] [Related]
11. Detoxification: what makes the difference?
Lloyd RA; Katon RN; DuPont RL; Rubenstein RM
Proc Natl Conf Methadone Treat; 1973; 1():275-83. PubMed ID: 4808159
[No Abstract] [Full Text] [Related]
12. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
13. Prevention of the diversion of clinic methadone to the street market.
Berger H
Proc Natl Conf Methadone Treat; 1973; 2():1264-6. PubMed ID: 4808277
[No Abstract] [Full Text] [Related]
14. Remarks on confidentiality.
Bryant TE
Proc Natl Conf Methadone Treat; 1973; 2():1427-30. PubMed ID: 4808297
[No Abstract] [Full Text] [Related]
15. Methadone maintenance.
Med Lett Drugs Ther; 1974 Dec; 16(26):110-1. PubMed ID: 4437478
[No Abstract] [Full Text] [Related]
16. Psychosocial and biomedical aspects of deaths associated with heroin and other narcotics.
Gottschalk LA; McGuire FL
NIDA Res Monogr; 1977 Nov; 16():122-9. PubMed ID: 97545
[TBL] [Abstract][Full Text] [Related]
17. [Methadone program in the USA. Experience and problems].
Riedesser P
Med Klin; 1974 Apr; 69(16):671-80. PubMed ID: 4600421
[No Abstract] [Full Text] [Related]
18. The use of propoxyphene napsylate in the treatment of heroin and methadone addiction.
Inaba DS; Gay GR; Whitehead CA; Newmeyer JA; Bergin D
West J Med; 1974 Aug; 121(2):106-11. PubMed ID: 4847425
[TBL] [Abstract][Full Text] [Related]
19. Amphetamines in the District of Columbia. III. Stimulant abuse in narcotics addicts in treatment, with an emphasis on phenmetrazine.
Greene MH; Turner N; DuPont RL
Int J Addict; 1974; 9(5):652-62. PubMed ID: 4155405
[No Abstract] [Full Text] [Related]
20. Characteristics of clients "enrolled" in an unauthorized methadone treatment program.
Goldberg EL; Nightingale SL
Proc Natl Conf Methadone Treat; 1973; 1():752-9. PubMed ID: 4808229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
